Urowitz M B
University of Toronto.
Rheum Dis Clin North Am. 1993 Feb;19(1):263-70.
Much of the initial attention in therapeutic studies for systemic lupus erythematosus (SLE) has justifiably been focused on the severe forms of the disease such as diffuse proliferative glomerulonephritis or central nervous system manifestations. Unfortunately, to all forms of SLE, thereby submitting patients with more benign variants of lupus have been submitted to aggressive, toxic, and probably unnecessary treatments. The thesis of this article is that aggressive therapy is not always necessary for SLE.
系统性红斑狼疮（SLE）治疗研究最初的许多关注都合理地集中在该疾病的严重形式上，如弥漫性增殖性肾小球肾炎或中枢神经系统表现。不幸的是，对于所有形式的SLE，患有狼疮较良性变体的患者因此接受了激进、有毒且可能不必要的治疗。本文的论点是，SLE并不总是需要激进治疗。
